SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201)

SARS-CoV-2 peptide LLLDRLNQL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from SARS-CoV-2 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: LLLDRLNQL
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

Uty peptide WMHHNMLDI (H-2 Db)

Uty peptide WMHHNMLDI (H-2 Db)

IBA Lifescience
Więcej
FAP peptide GLSGLSTNHL (HLA-A*0201)

FAP peptide GLSGLSTNHL (HLA-A*0201)

IBA Lifescience
Więcej
MHC I-Strep HLA-A*0201; EBV BMLF1 (GLCTLVAML)

MHC I-Strep HLA-A*0201; EBV BMLF1 (GLCTLVAML)

IBA Lifescience
Więcej